-
IntroducedDec 23, 2025
-
Passed SenateFeb 19, 2026
-
Passed HouseApr 16, 2026
-
Became LawMay 05, 2026
Tennessee Senate Bill
Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33. SB1495 has been assigned Public Chapter Number 888 by the Secretary of State.
Last Action See all actions
executive • May 18, 2026: Effective date(s) 05/05/2026
Latest Bill Text See all bill texts
Summary
Comments on SB 1495
Tweets
Whip Lists
Sponsors
Votes
YES: 8
NO: 0
OTHER: 0
YES: 8
NO: 0
OTHER: 0
YES: 31
NO: 0
OTHER: 0
YES: 16
NO: 0
OTHER: 0
YES: 13
NO: 0
OTHER: 0
YES: 27
NO: 0
OTHER: 0
YES: 0
NO: 0
OTHER: 0
YES: 87
NO: 0
NOT VOTING: 1
Actions
- May 18, 2026 | executive
- Pub. Ch. 888
- Effective date(s) 05/05/2026
- May 05, 2026 | Senate
- Signed by Governor.
- Apr 23, 2026 | Senate
- Transmitted to Governor for action.
- Apr 22, 2026 | Senate
- Signed by Senate Speaker
- Apr 21, 2026 | House
- Signed by H. Speaker
- Apr 21, 2026 | Senate
- Signed by Senate Speaker
- Apr 20, 2026 | Senate
- Enrolled and ready for signatures
- Apr 16, 2026 | House
- Subst. for comp. HB.
- Passed H., Ayes 87, Nays 0, PNV 1
- Feb 23, 2026 | House
- Rcvd. from S., held on H. desk.
- Feb 19, 2026 | Senate
- Passed Senate, Ayes 31, Nays 0
- Engrossed; ready for transmission to House
- Feb 17, 2026 | Senate
- Placed on Senate Consent Calendar 2 for 2/19/2026
- Feb 10, 2026 | Senate
- Recommended for passage, refer to Senate Calendar Committee
- Feb 03, 2026 | Senate
- Placed on Senate Judiciary Committee calendar for 2/10/2026
- Jan 14, 2026 | Senate
- Passed on Second Consideration, refer to Senate Judiciary Committee
- Jan 13, 2026 | Senate
- Introduced, Passed on First Consideration
- Dec 23, 2025 | Senate
- Filed for introduction
Bill Texts

